Strategies to Enhance the Efficacy of T-Cell Therapy for Central Nervous System Tumors
Mortality rates in patients diagnosed with central nervous system (CNS) tumors, originating in the brain or spinal cord, continue to remain high despite the advances in multimodal treatment regimens, including surgery, radiation, and chemotherapy. Recent success of adoptive cell transfer immunothera...
Main Authors: | Deepak Upreti, David Bakhshinyan, Darin Bloemberg, Parvez Vora, Chitra Venugopal, Sheila K. Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.599253/full |
Similar Items
-
Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System
by: Mohini Singh, et al.
Published: (2017-09-01) -
Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma
by: Tiarne van de Walle, et al.
Published: (2021-09-01) -
Central nervous system tumors: Radiologic pathologic correlation and diagnostic approach
by: Ishita Pant, et al.
Published: (2015-02-01) -
Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies
by: Neil M D'Souza, et al.
Published: (2016-10-01) -
Revisiting metastatic central nervous system tumors with unknown primary using clinicopathological findings: A single neurosciences institutional study
by: Anshu Gupta, et al.
Published: (2019-01-01)